[Progress in the therapy of parkinsonism with L-dopa: inhibition of dopa decarboxylase].
D000311:Adrenal Glands / Q000378:metabolism; D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001921:Brain / Q000201:enzymology* / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004296:Dopa Decarboxylase / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D006168:Guinea Pigs; D007413:Intestinal Mucosa / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D007980:Levodopa / Q000627:therapeutic use*; D008099:Liver / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy*; D011817:Rabbits; D051381:Rats; D013154:Spleen / Q000378:metabolism
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D007980:Levodopa; D004295:Dihydroxyphenylalanine; D004296:Dopa Decarboxylase; D004298:Dopamine
Progressi nella terapia del Parkinson con L-dopa: l'inibizione della dopa-decarbossilasi